SOURCE: Dynavax Technologies

Dynavax Technologies

June 11, 2013 00:11 ET

Dynavax to Present at the William Blair 33rd Annual Growth Stock Conference

BERKELEY, CA--(Marketwired - Jun 11, 2013) -  Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the William Blair 33rd Annual Growth Stock Conference in Chicago on Tuesday, June 11, at 10:10 a.m. EDT (7:10 a.m. PDT).

Michael Ostrach, Chief Business Officer of Dynavax, will provide a corporate overview presentation. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at http://investors.dynavax.com/newsevents.cfm.

About Dynavax
Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine. For more information visit www.dynavax.com

Contact Information

  • Contact:
    Michael Ostrach
    Vice President and Chief Business Officer
    510-665-7257
    Email Contact